Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate.

Jones NS, Winter H, Katsumoto TR, Florero M, Murray E, Walker H, Singh N, Chinn LW.

J Pharmacol Exp Ther. 2019 Oct;371(1):202-207. doi: 10.1124/jpet.119.257089. Epub 2019 Aug 1.

2.

Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies.

Lippner EA, Lewis DB, Robinson WH, Katsumoto TR.

Curr Treat Options Oncol. 2019 Jun 22;20(7):62. doi: 10.1007/s11864-019-0661-2. Review.

PMID:
31227926
3.

Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis.

Gomez Mendez LM, Cascino MD, Katsumoto TR, Brakeman P, Brunetta P, Jayne D, Dall'Era M, Rovin B, Garg J.

Lupus Sci Med. 2019 Feb 4;6(1):e000308. doi: 10.1136/lupus-2018-000308. eCollection 2019.

4.

Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis.

Gomez Mendez LM, Cascino MD, Garg J, Katsumoto TR, Brakeman P, Dall'Era M, Looney RJ, Rovin B, Dragone L, Brunetta P.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1502-1509. doi: 10.2215/CJN.01070118. Epub 2018 Aug 8. Erratum in: Clin J Am Soc Nephrol. 2019 Jan 7;14(1):111.

PMID:
30089664
5.

Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor.

Herman AE, Chinn LW, Kotwal SG, Murray ER, Zhao R, Florero M, Lin A, Moein A, Wang R, Bremer M, Kokubu S, Serone AP, Hanze EL, Viberg A, Morimoto AM, Winter HR, Katsumoto TR.

Clin Pharmacol Ther. 2018 Jun;103(6):1020-1028. doi: 10.1002/cpt.1056. Epub 2018 Mar 23.

PMID:
29484638
6.

Brief Report: Whole-Exome Sequencing for Identification of Potential Causal Variants for Diffuse Cutaneous Systemic Sclerosis.

Mak AC, Tang PL, Cleveland C, Smith MH, Kari Connolly M, Katsumoto TR, Wolters PJ, Kwok PY, Criswell LA.

Arthritis Rheumatol. 2016 Sep;68(9):2257-62. doi: 10.1002/art.39721.

7.

Outcomes in systemic sclerosis-related lung disease after lung transplantation.

Sottile PD, Iturbe D, Katsumoto TR, Connolly MK, Collard HR, Leard LA, Hays S, Golden JA, Hoopes C, Kukreja J, Singer JP.

Transplantation. 2013 Apr 15;95(7):975-80. doi: 10.1097/TP.0b013e3182845f23.

8.

The phosphatase CD148 promotes airway hyperresponsiveness through SRC family kinases.

Katsumoto TR, Kudo M, Chen C, Sundaram A, Callahan EC, Zhu JW, Lin J, Rosen CE, Manz BN, Lee JW, Matthay MA, Huang X, Sheppard D, Weiss A.

J Clin Invest. 2013 May;123(5):2037-48. doi: 10.1172/JCI66397. Epub 2013 Apr 1.

9.

Cut to the quick.

Su R, Katsumoto TR, George V, Gundling K, Hollander H.

J Hosp Med. 2013 Feb;8(2):110-3. doi: 10.1002/jhm.2000. Epub 2013 Jan 3. No abstract available.

PMID:
23288681
10.

Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.

Lee JS, Kim EJ, Lynch KL, Elicker B, Ryerson CJ, Katsumoto TR, Shum AK, Wolters PJ, Cerri S, Richeldi L, Jones KD, King TE Jr, Collard HR.

Respir Med. 2013 Feb;107(2):249-55. doi: 10.1016/j.rmed.2012.10.018. Epub 2012 Nov 24.

11.

Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease.

Katsumoto TR, Violette SM, Sheppard D.

Int J Rheumatol. 2011;2011:208219. doi: 10.1155/2011/208219. Epub 2011 Oct 16.

12.

Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'.

Goodridge HS, Reyes CN, Becker CA, Katsumoto TR, Ma J, Wolf AJ, Bose N, Chan AS, Magee AS, Danielson ME, Weiss A, Vasilakos JP, Underhill DM.

Nature. 2011 Apr 28;472(7344):471-5. doi: 10.1038/nature10071.

13.

The pathogenesis of systemic sclerosis.

Katsumoto TR, Whitfield ML, Connolly MK.

Annu Rev Pathol. 2011;6:509-37. doi: 10.1146/annurev-pathol-011110-130312. Review.

PMID:
21090968
14.

Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling.

Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A.

Immunity. 2008 Feb;28(2):183-96. doi: 10.1016/j.immuni.2007.11.024. Epub 2008 Jan 31.

15.

Granulocyte/macrophage colony-stimulating factor and accessory cells modulate radioprotection by purified hematopoietic cells.

Katsumoto TR, Duda J, Kim A, Wardak Z, Dranoff G, Clapp DW, Shannon K.

J Exp Med. 2005 Mar 21;201(6):853-8.

16.

Polymerized liposome assemblies: bifunctional macromolecular selectin inhibitors mimicking physiological selectin ligands.

Bruehl RE, Dasgupta F, Katsumoto TR, Tan JH, Bertozzi CR, Spevak W, Ahn DJ, Rosen SD, Nagy JO.

Biochemistry. 2001 May 22;40(20):5964-74.

PMID:
11352731
17.

Ligation of L-selectin on T lymphocytes activates beta1 integrins and promotes adhesion to fibronectin.

Giblin PA, Hwang ST, Katsumoto TR, Rosen SD.

J Immunol. 1997 Oct 1;159(7):3498-507.

PMID:
9317149
18.

L-selectin-carbohydrate interactions: relevant modifications of the Lewis x trisaccharide.

Sanders WJ, Katsumoto TR, Bertozzi CR, Rosen SD, Kiessling LL.

Biochemistry. 1996 Nov 26;35(47):14862-7.

PMID:
8942649

Supplemental Content

Loading ...
Support Center